SEC Form 4 · accession 0001179022-15-000009
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter G Traber
Officer — President & CEO
Period of report
Jan 29, 2015
Accepted (ET)
Feb 2, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $3.45 | Jan 29, 2015 | A | 134,000 | A | — | Jan 29, 2025 | Common stock | 134,000 | 134,000 | D |
Explanation of responses
- F1The options vest as follows: 25% immediately, and the remaining 75% in equal installments on a monthly basis over a period of three years.
Remarks
Exhibit Index: Exhibit 24 - Power of Attorney